We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$45.3M
2
MDVN
MEDIVATION, INC.
MDVN
+$33.2M
3
DHR icon
Danaher
DHR
+$28.3M
4
FLTX
Fleetmatics Group PLC
FLTX
+$25.2M
5
HCSG icon
Healthcare Services Group
HCSG
+$24.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
126
Verizon
VZ
$198B
$23M 0.2%
442,280
-15,131
-3% -$812K
ILMN icon
127
Illumina
ILMN
$30.6B
$22.8M 0.2%
129,296
+7,242
+6% +$1.16M
SJM icon
128
J.M. Smucker
SJM
$12.6B
$22.8M 0.2%
167,846
+9,909
+6% +$1.45M
LKQ icon
129
LKQ Corp
LKQ
$5.88B
$22.7M 0.2%
639,337
+95,793
+18% +$3.32M
EPD icon
130
Enterprise Products Partners
EPD
$81.5B
$22.5M 0.2%
813,836
-6,441
-0.8% -$178K
ZD icon
131
Ziff Davis
ZD
$2.02B
$22.3M 0.2%
385,498
+123,523
+47% +$7.19M
PLAY icon
132
Dave & Buster's
PLAY
$404M
$22.2M 0.2%
566,125
+23,424
+4% +$1.04M
TMO icon
133
Thermo Fisher Scientific
TMO
$214B
$21.8M 0.19%
137,273
+3,881
+3% +$598K
EXEL icon
134
Exelixis
EXEL
$13.6B
$21.7M 0.19%
1,693,190
+1,286,800
+317% +$13.9M
WMT icon
135
Walmart Inc
WMT
$879B
$21.5M 0.19%
892,986
-1,368
-0.2% -$33.2K
NXTM
136
DELISTED
NxStage Medical Inc.
NXTM
$21.4M 0.19%
857,861
-328,381
-28% -$7.66M
TIP icon
137
iShares TIPS Bond ETF
TIP
$14.5B
$21.3M 0.19%
182,637
-1,148
-0.6% -$133K
AKAM icon
138
Akamai
AKAM
$17.2B
$21.1M 0.19%
398,237
+43,562
+12% +$2.33M
PXD
139
DELISTED
Pioneer Natural Resource Co.
PXD
$21.1M 0.19%
113,457
-2,358
-2% -$401K
CSCO icon
140
Cisco
CSCO
$454B
$21.1M 0.19%
663,802
-118,179
-15% -$3.64M
VIG icon
141
Vanguard Dividend Appreciation ETF
VIG
$111B
$20.8M 0.18%
248,194
+6,812
+3% +$577K
MJN
142
DELISTED
Mead Johnson Nutrition Company
MJN
$20.7M 0.18%
262,397
+81,888
+45% +$6.98M
PM icon
143
Philip Morris
PM
$296B
$20.6M 0.18%
212,348
-788
-0.4% -$78.9K
ISRG icon
144
Intuitive Surgical
ISRG
$134B
$20.3M 0.18%
252,198
+1,764
+0.7% +$135K
MRK icon
145
Merck
MRK
$315B
$20.1M 0.18%
337,093
+11,295
+3% +$661K
IEMG icon
146
iShares Core MSCI Emerging Markets ETF
IEMG
$151B
$19.9M 0.18%
435,981
+17,757
+4% +$789K
MORN icon
147
Morningstar
MORN
$7.4B
$19.9M 0.18%
250,565
-3,569
-1% -$293K
CMG icon
148
Chipotle Mexican Grill
CMG
$47.3B
$19.8M 0.18%
2,342,200
+369,000
+19% +$3.03M
CHD icon
149
Church & Dwight Co
CHD
$23.8B
$19.8M 0.17%
412,978
+19,192
+5% +$947K
BA icon
150
Boeing
BA
$179B
$19.6M 0.17%
148,787
-2,876
-2% -$379K
4 5
6
7 8

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.